647 related articles for article (PubMed ID: 19031020)
1. Dendritic cell migration to peripheral lymph nodes.
Martín-Fontecha A; Lanzavecchia A; Sallusto F
Handb Exp Pharmacol; 2009; (188):31-49. PubMed ID: 19031020
[TBL] [Abstract][Full Text] [Related]
2. Dendritic-cell trafficking to lymph nodes through lymphatic vessels.
Randolph GJ; Angeli V; Swartz MA
Nat Rev Immunol; 2005 Aug; 5(8):617-28. PubMed ID: 16056255
[TBL] [Abstract][Full Text] [Related]
3. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
[TBL] [Abstract][Full Text] [Related]
4. Lymph node homing of T cells and dendritic cells via afferent lymphatics.
Förster R; Braun A; Worbs T
Trends Immunol; 2012 Jun; 33(6):271-80. PubMed ID: 22459312
[TBL] [Abstract][Full Text] [Related]
5. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
6. T cell priming by tissue-derived dendritic cells: new insights from recent murine studies.
Sillé FC; Visser A; Boes M
Cell Immunol; 2005 Oct; 237(2):77-85. PubMed ID: 16360134
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
[TBL] [Abstract][Full Text] [Related]
8. Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction.
Contassot E; Preynat-Seauve O; French L; Huard B
Trends Immunol; 2009 Dec; 30(12):569-73. PubMed ID: 19837632
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecules in human dendritic cells.
Rodríguez-Fernández JL; Corbí AL
Curr Opin Investig Drugs; 2005 Nov; 6(11):1103-11. PubMed ID: 16312130
[TBL] [Abstract][Full Text] [Related]
10. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules.
Yoneyama H; Matsuno K; Zhang Y; Nishiwaki T; Kitabatake M; Ueha S; Narumi S; Morikawa S; Ezaki T; Lu B; Gerard C; Ishikawa S; Matsushima K
Int Immunol; 2004 Jul; 16(7):915-28. PubMed ID: 15159375
[TBL] [Abstract][Full Text] [Related]
11. CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming.
Martín-Fontecha A; Baumjohann D; Guarda G; Reboldi A; Hons M; Lanzavecchia A; Sallusto F
J Exp Med; 2008 Oct; 205(11):2561-74. PubMed ID: 18838544
[TBL] [Abstract][Full Text] [Related]
12. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes.
Stoll S; Delon J; Brotz TM; Germain RN
Science; 2002 Jun; 296(5574):1873-6. PubMed ID: 12052961
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells: tools and targets for antitumor vaccination.
den Brok MH; Nierkens S; Figdor CG; Ruers TJ; Adema GJ
Expert Rev Vaccines; 2005 Oct; 4(5):699-710. PubMed ID: 16221071
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells and their role in cancer immunotherapy.
Jalili A
Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
[TBL] [Abstract][Full Text] [Related]
16. Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice.
Sangaletti S; Gioiosa L; Guiducci C; Rotta G; Rescigno M; Stoppacciaro A; Chiodoni C; Colombo MP
J Cell Sci; 2005 Aug; 118(Pt 16):3685-94. PubMed ID: 16046482
[TBL] [Abstract][Full Text] [Related]
17. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo.
Garg S; Oran A; Wajchman J; Sasaki S; Maris CH; Kapp JA; Jacob J
Nat Immunol; 2003 Sep; 4(9):907-12. PubMed ID: 12910266
[TBL] [Abstract][Full Text] [Related]
18. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model.
Barratt-Boyes SM; Watkins SC; Finn OJ
J Immunol; 1997 May; 158(10):4543-7. PubMed ID: 9144465
[TBL] [Abstract][Full Text] [Related]
19. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.
De Vries IJ; Krooshoop DJ; Scharenborg NM; Lesterhuis WJ; Diepstra JH; Van Muijen GN; Strijk SP; Ruers TJ; Boerman OC; Oyen WJ; Adema GJ; Punt CJ; Figdor CG
Cancer Res; 2003 Jan; 63(1):12-7. PubMed ID: 12517769
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
